Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
0.13 0.00(0.00%) Feb 12, 4:00PM EST
Prev Close:0.13
Open:0.14
Bid:N/A
Ask:0.15 x 6000
1y Target Est:2.42
Beta:3.48407
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:0.13 - 0.15
52wk Range:0.13 - 1.47
Volume:1,408,337
Avg Vol (3m):1,760,920
Market Cap:25.94M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTX 0.00%25.94M
BAXUp 2.03%20.03B
OSIRDown 0.30%229.46M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.19
Quarterly EPS Est (Dec-15) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback